Niraparib maintenance therapy using an individualised starting dose in patients with platinum-sensitive recurrent ovarian cancer (NORA): final overall survival analysis of a phase 3 randomised, placebo-controlled trial
-
Published:2024-06
Issue:
Volume:72
Page:102629
-
ISSN:2589-5370
-
Container-title:eClinicalMedicine
-
language:en
-
Short-container-title:eClinicalMedicine
Author:
Wu Xiaohua, Zhu JianqingORCID, Yin Rutie, Yang Jiaxin, Liu Jihong, Wang Jing, Wu Lingying, Liu Ziling, Gao Yunong, Wang Danbo, Lou Ge, Yang Hongying, Zhou Qi, Kong Beihua, Huang Yi, Chen Lipai, Li Guiling, An Ruifang, Wang Ke, Zhang Yu, Yan Xiaojian, Lu Xin, Lu Weiguo, Hao Min, Wang Li, Cui Heng, Chen Qionghua, Abulizi Guzhalinuer, Huang Xianghua, Tian Xiaofei, Wen Hao, Huang Zhao, Dong Juan, Zhang Charlie, Hou Jianmei, Mirza Mansoor R.
|
|